GLP-1 and Dexcom G7:
managing diabetes
better together
GLP-1… meet your perfect match. Dexcom G7: the first and only continuous glucose monitoring (CGM) system
with medication logging.*
By pairing Dexcom G7 with your GLP-1† therapy, you can track your success in real time and accelerate your progress towards your diabetes health goals.1
The perfect pairing for lowering A1C
Using Dexcom G7 alongside your GLP-1 therapy can lead to a lower A1C than GLP-1 therapy alone.1 Combining the two helps you realize your goals more quickly.1
First and only CGM with medication logging*
This unique feature allows you to log your specific medication dose and when you took it, so you can see exactly how it affects your glucose throughout the day.
Confident choices.
Better outcomes.
Dexcom G7 is easy to use and allows you to see how food, medication, and activity affect your glucose levels in real time.
The more you see what’s happening with your body, the more confident you’ll be making everyday decisions that impact your overall health.
Track your success with the most accurate CGM2
There’s no need to wait another three months for your next A1C test to check your progress. Instead, you can get an ongoing estimate of your A1C in as little as two weeks - this estimate is shown as your GMI or Glucose Management Indicator. This enables you to see your successes, stay motivated, and continue making progress towards your diabetes goals.
#1 recommended brand by patients and doctors3,4
For 25 years, Dexcom has led the way with innovative technology that makes managing diabetes easier. Dexcom CGM Systems also allow doctors to see patients’ CGM data,‡ which can help them make recommendations about medication and lifestyle modifications.
Most affordable CGM brand§,6
Dexcom is the most covered CGM brand,6 and most covered patients pay $0 or less per month.|| Even if you don’t have coverage, you can take advantage of our pharmacy savings program and save over 50%.
Get Started with Dexcom
Take the first step towards better health! Glucose health is a critical part of overall health, and Dexcom has the best sensing solution for you or your loved one regardless of your health goals. We'll make getting started easy from the comfort of your home.
Our experts are here to help.
*Medication logging available in the Dexcom G7 app only. †GLP-1 refers to the GLP-1 receptor agonists class of drugs. ‡Patient must first sync their Dexcom G6 or G7 data with the Dexcom Clarity app and consent to share their data with their healthcare provider. An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. §Most affordable refers to claims at pharmacy. Individual pricing may vary depending on insurance coverage. ||Individual pricing may vary depending on insurance coverage. IQVIA FIA retail data, paid sensor claims from 1/1/2022 to 2/28/2023.
1 Nemlekar et al. Diabetes Technol Ther. 2024;26(Supp 2):A206-7. 2 Dexcom, data on file. 2023. 3 dQ&A US Q1 2023 US Diabetes Connections Patient Panel Report. 4 Seagrove HCP Survey Q2 2022. 5 Baird GLP-1 Impact Report, September 2023. 6 Dexcom, data on file. 2024.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2024 Dexcom, Inc. All rights reserved.